Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press7910.17650/1726-9776-2012-8-1-36-42DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCERДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак мочевого пузыряRETROSPECTIVE ANALYSIS OF THE RESULTS OF RADICAL CYSTECTOMY IN NON-MUSCLE INVASIVE BLADDER CANCERСРАВНИТЕЛЬНЫЙ АНАЛИЗ РЕЗУЛЬТАТОВ РАДИКАЛЬНОЙ ЦИСТЭКТОМИИ И КИШЕЧНОЙ ДЕРИВАЦИИ МОЧИ ПРИ ВЫПОЛНЕНИИ МЕЖКИШЕЧНЫХ АНАСТОМОЗОВ АППАРАТНЫМ И РУЧНЫМ ШВОМKoganM. I.КоганМ. И.
Russian Federation

Department of Urology and Human Reproductive Health with a Course of Pediatric Urology-Andrology,Rostov State Medical University

кафедра урологии и репродуктивного здоровья человека с курсом детской урологии-андрологии Ростовского ГМУ

dept_kogan@mail.ruVasilyevO. N.ВасильевО. Н.
Russian Federation

Department of Urology and Human Reproductive Health with a Course of Pediatric Urology-Andrology,Rostov State Medical University

кафедра урологии и репродуктивного здоровья человека с курсом детской урологии-андрологии Ростовского ГМУ

dept_kogan@mail.ruResearch Institute of Urology and Nephrology, Rostov-on-DonНИИ урологии и нефрологии, Ростов-на-Дону300320128136422607201426072014https://oncourology.abvpress.ru/oncur/article/view/79

The results of treatment were analyzed in 53 patients with high-risk non-muscle invasive bladder cancer (BC), who had undergone radical cystectomy (RCE) and bilateral pelvic lymphadenectomy. Histological hypostaging was noted in 20.7% of the patients; 13.2% of them had regional lymph node metastases, which confirms the problems associated with the accurate determination of a BC stage in clinical stage T1. The predictors of lower cancer-specific survival were identified in patients after RCE for pT1 cancer. In our study, 5- and 10-year cancer-specific survival was 90.5 and 88.6% in cT1 stage and 98.2 and 96.3% in pT1 stage, respectively. The findings strongly suggest that RCE can afford a long-term high cancer-specific survival in patients with non-muscle invasive BC.

non-muscle invasive bladder canceradical cystectomsurvivalcarcinoma in situhypostagingрак мочевого пузырярадикальная цистэктомиямежкишечный анастомозвыживаемостьпослеоперационные осложнения1. Baumgartner R.G., Wells N., Chang S.S. et al. Causes of increased length of stay following radical cystectomy. Urol Nurs 2002;22(5):319−23.Baumgartner R.G., Wells N., Chang S.S. et al. Causes of increased length of stay following radical cystectomy. Urol Nurs 2002;22(5):319−23.2. Bergqvist D. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Br J Surg 2004;91:965−74.Bergqvist D. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Br J Surg 2004;91:965−74.3. Chang S.S., Cookson M.S., Baumgartner R.G. et al. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002;167:2012−6.Chang S.S., Cookson M.S., Baumgartner R.G. et al. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002;167:2012−6.4. Skinner D.G., Crawford E.D., Kaufman J.J. Complications of radical cystectomy for carcinoma of the bladder. J Urol 1980;123(5):640−3.Skinner D.G., Crawford E.D., Kaufman J.J. Complications of radical cystectomy for carcinoma of the bladder. J Urol 1980;123(5):640−3.5. Figueroa A.J., Stein J.P., Dickinson M. et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer 1998; 83:141−7.Figueroa A.J., Stein J.P., Dickinson M. et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer 1998; 83:141−7.6. Ghoneim M.A., El-Mekresh M.M., El-Baz M.A. et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 1997;158(2):393–9.Ghoneim M.A., El-Mekresh M.M., El-Baz M.A. et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 1997;158(2):393–9.7. Koch M.O., Seckin B., Smith J.A., Jr. Impact of a collaborative care approach to radical cystectomy and urinary reconstruction. J Urol 1995;154:996–1001.Koch M.O., Seckin B., Smith J.A., Jr. Impact of a collaborative care approach to radical cystectomy and urinary reconstruction. J Urol 1995;154:996–1001.8. Pagano F., Bassi P., Caletti T.P. et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45−50.Pagano F., Bassi P., Caletti T.P. et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991;145:45−50.9. Froehner M., Brausi M.A., Herr H.W. et al. Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009;56:443–54.Froehner M., Brausi M.A., Herr H.W. et al. Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009;56:443–54.10. Novara G., De Marco V., Aragona M. et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182:914–21.Novara G., De Marco V., Aragona M. et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182:914–21.11. Rosario D.J., Becker M., Anderson J.B. The changing pattern of mortality and morbidity from radical cystectomy. BJU Int 2000;85:427−30.Rosario D.J., Becker M., Anderson J.B. The changing pattern of mortality and morbidity from radical cystectomy. BJU Int 2000;85:427−30.12. Hollenbeck B.K., Miller D.C., Taub D. et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005;174:1231–7.Hollenbeck B.K., Miller D.C., Taub D. et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005;174:1231–7.13. Chang S.S., Cookson M.S., Baumgartner R.G. et al. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002; 167:2012–6.Chang S.S., Cookson M.S., Baumgartner R.G. et al. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002; 167:2012–6.14. Tzortzis V., Gravas S., Mitsogiannis I.C. et al. Impact of stapling devices on radical cystectomy: comparative study between low- and high-volume surgeons. J Urol 2008; 71(2):337–40.Tzortzis V., Gravas S., Mitsogiannis I.C. et al. Impact of stapling devices on radical cystectomy: comparative study between low- and high-volume surgeons. J Urol 2008; 71(2):337–40.15. Hautmann R.E., Petriconi R.C., Volkmer B.G. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol 2010;184:990−4.Hautmann R.E., Petriconi R.C., Volkmer B.G. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol 2010;184:990−4.16. Cookson M.S., Chang S.S., Wells N. et al. Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease. J Urol 2003;169:101–4.Cookson M.S., Chang S.S., Wells N. et al. Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease. J Urol 2003;169:101–4.17. Lowrance W.T., Rumohr J.A., Chang S.S. et al. Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol 2008;179:1313−8.Lowrance W.T., Rumohr J.A., Chang S.S. et al. Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol 2008;179:1313−8.